administration

DRUG2 trials

Sponsors

Fondazione Santa Lucia, Center for Pharmaceutical Research and Development, Havana, Cuba.

Conditions

Healthy volunteerssubstance use disorder

Phase 1

Bioequivalence of Diltiazem retard

Active, not recruitingRPCEC00000260

Center for Pharmaceutical Research and Development, Havana, Cuba.Healthy volunteers

Start: 2018-10-01Target: 24Updated: 2026-04-27

Phase 2

Oral rifaximin in patients with opioid use disorder (OUD): multicenter clinical trial on the microbiota–gut–brain axis

WithdrawnCTIS2025-524778-41-00

Fondazione Santa Luciasubstance use disorder

Target: 50Updated: 2026-04-29